WAY
WaystarBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-23
Current thesis
The cleanest bull read is that Q1 kept growth quality high: revenue grew 22%, subscription revenue outgrew total revenue, EBITDA margin stayed strong, and client metrics remained healthy, which supports a software-compounder framing if AI and Iodine add incremental upsell.
Posture
Constructive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-07-29 · AMC.
What can break
Execution on the Iodine acquisition is still a key swing factor; the company explicitly flags acquisition integration risk in its filings.
Momentum
44
Value
63
Sentiment
65
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $27.00 · Bull $34.00 · Bear $16.00
Earnings
2026-07-29 · AMC
Data freshness
Prices
As of 2026-07-23
Fundamentals
As of 2026-07-23 • Vendor: Data Vendor v1
Scores
As of 2026-07-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-05 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-23
Investment thesis
As of 2026-07-23
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $33.74
Why
Momentum44 · Δ7d -9.3
Value63 · Δ7d +0.7
Sentiment65 · Δ7d +9.2
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
44
26% active weight
Current posture
7d trendSoftening
Δ7d
-9.3
Δ21d
+30.1
Value
63
39% active weight
Current posture
7d trendFlat
Δ7d
+0.7
Δ21d
+1.1
Sentiment
65
34% active weight
Current posture
7d trendImproving
Δ7d
+9.2
Δ21d
+1.0
Why this grade
Composite grade B. Momentum 44.1 / Value 63.2 / Sentiment 65.3
Fundamentals (TTM)As of 2026-07-23
Fundamentals (TTM)
As of 2026-07-23
Market Cap
$4.14B
Beta
-
Shares Out
191.81M
P/E (TTM)
51.4
P/S (TTM)
5.85
P/FCF (TTM)
21.37
Rev YoY
+22.4%
EPS YoY
+36.9%
Gross Margin
+55.9%
Op Margin
+23.4%
Net Debt
$1.39B
Current Ratio
1.76
As of 2026-07-23 • Updated nightlySource: Internal modelMethodology